Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

Published:2012 Issue:1 Volume:5 Page:23
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:Journal of Ovarian Research

Author:

Madsen Christine,Steffensen Karina,Olsen Dorte,Waldstrøm Marianne,Smerdel Maja,Adimi Parvin,Brandslund Ivan,Jakobsen Anders

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Reference28 articles.

1. What Is the Evidence That Tumors Are Angiogenesis Dependent?

2. Angiogenesis as a therapeutic target

3. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

4. A Phase 3 Trial of Bevacizumab in Ovarian Cancer

5. OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer;Scientific Reports;2023-11-27

2. Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine;Frontiers in Pharmacology;2023-03-07

3. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer;Gynecologic Oncology;2023-03

4. Colorimetric Biosensors Based on Polymer/Gold Hybrid Nanoparticles: Topological Effects of the Polymer Coating;Langmuir;2022-09-26

5. Bisphenol analogs AF and S: Effects on cell status and production of angiogenesis-related factors by COV434 human granulosa cell line;Toxicology and Applied Pharmacology;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3